Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


BioMedical Innovations adds Dr. Stephen Fry as Managing Partner for Medical Technology VC Fund

BioMedical Innovations Adds Dr. Stephen M. Fry as Managing Partner

Zurich, Switzerland, July 6, 2006 BioMedical Innovations Management Ltd, a leading venture capital investment management firm focused on the European and Israeli Medical Technology sector, is pleased to announce the expansion of the management team with the addition of Dr. Stephen M. Fry.

Dr. Fry has over 20 years of experience in the Medical Technology sector as former Head of R&D and CTO of Volcano Therapeutics Inc. (NASDAQ: VOLC), as founder and CEO of SBDI, a leading Medical Technology consulting firm with over 100 clients, as founder and CEO of TomoTherapeutics, Inc. and IntraVascular Medical, Inc. (EndiCOR Medical, acquired by EV3), as General Manager of the Medical Laser Center of Baxter Healthcare Corp., and as Director of Business Development for American Hospital Supply Corp.(Baxter Healthcare). He has published more than 50 papers and book chapters, and authored or co-authored more than a dozen books on medical devices. Dr. Fry has a B.S. in Physics, an M.S. in Electrical Engineering, and a Ph.D. in Quantum Electronics from U.C.L.A., and an M.B.A. in Financial Analysis from National University.

Dr. Fry will primarily be based in the US and support the current management team with his technical, clinical and market expertise for its upcoming second Fund, BioMedical Innovations L.P. Fund II (BMI II). BMI II is expected to become the first pan-European VC Fund focused exclusively on Medical Technology. Dr. Fry ideally complements the existing management team with his in-depth knowledge of the US Medical Technology sector, the key distribution and exit market also for European and Israeli companies active in the field.

About BioMedical Innovations Ltd.
BioMedical Innovations Management Ltd. is a venture capital management company with a focus on medical technology and life science tools investments in Europe, including Israel. The Medical Technology and Life Science Tools sectors offer shorter-term, less capital-intensive healthcare technology investments with attractive risk/return characteristics. The investment team has a strong track-record in hands-on start-up management and healthcare capital market credentials, and an extensive network in industry, science and finance.

Mikael von Euw
BioMedical Innovations Ltd.
Phone +41 43 344 5708
Fax +41 43 344 5709

Publisher Contact Information:

BioMedical Innovations Ltd.
+41 43 344 5708

Company profile of BioMedical Innovations Ltd.
Past press releases of BioMedical Innovations Ltd..


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Nov 8N/AOther Computers & Electronics
Nov 5€2.1MAudio/Video
Nov 5€5.2MOther Computers & Electronics
Nov 5€0.4MInternet services
Nov 5€1.3MSecurity
Nov 5€1.5MAudio/Video

For information on Europe's most extensive database on technology funding click here!


Press Releases

Sep 30
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Mar 31
the fit allocates chf 100'000 to comppair technologies

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.